Superiority of dendritic cell vaccine vs tumor cell vaccine: survival by stratification subsets in MACVAC randomized Phase II trial of patient-specific vaccines utilizing antigens from autologous melanoma tumor cell lines
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P202
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dillman, Robert O
McClay, Edward
Amatruda, Thomas
Semeniuk, George
Haskins, Clark
Weber, Robert
Burtzo, David
DePriest, Carol
Carbonell, Denysha
Cornforth, Andrew
Article History
First Online: 4 November 2015